1-214641961-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016343.4(CENPF):​c.3623C>T​(p.Ala1208Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00896 in 1,599,682 control chromosomes in the GnomAD database, including 160 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0098 ( 22 hom., cov: 33)
Exomes 𝑓: 0.0089 ( 138 hom. )

Consequence

CENPF
NM_016343.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.61

Publications

9 publications found
Variant links:
Genes affected
CENPF (HGNC:1857): (centromere protein F) This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]
CENPF Gene-Disease associations (from GenCC):
  • Stromme syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026867688).
BP6
Variant 1-214641961-C-T is Benign according to our data. Variant chr1-214641961-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00978 (1488/152162) while in subpopulation NFE AF = 0.00941 (640/67998). AF 95% confidence interval is 0.00881. There are 22 homozygotes in GnomAd4. There are 859 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CENPFNM_016343.4 linkc.3623C>T p.Ala1208Val missense_variant Exon 12 of 20 ENST00000366955.8 NP_057427.3 P49454
CENPFXM_017000086.3 linkc.3623C>T p.Ala1208Val missense_variant Exon 12 of 20 XP_016855575.1 P49454
CENPFXM_011509082.4 linkc.3623C>T p.Ala1208Val missense_variant Exon 12 of 19 XP_011507384.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CENPFENST00000366955.8 linkc.3623C>T p.Ala1208Val missense_variant Exon 12 of 20 1 NM_016343.4 ENSP00000355922.3 P49454
CENPFENST00000706765.1 linkc.3623C>T p.Ala1208Val missense_variant Exon 12 of 19 ENSP00000516538.1 A0A9L9PXU7

Frequencies

GnomAD3 genomes
AF:
0.00979
AC:
1488
AN:
152046
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00143
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00766
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00455
Gnomad FIN
AF:
0.0579
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00941
Gnomad OTH
AF:
0.00863
GnomAD2 exomes
AF:
0.0118
AC:
2774
AN:
234930
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.00139
Gnomad AMR exome
AF:
0.00499
Gnomad ASJ exome
AF:
0.00432
Gnomad EAS exome
AF:
0.0000567
Gnomad FIN exome
AF:
0.0589
Gnomad NFE exome
AF:
0.0101
Gnomad OTH exome
AF:
0.0146
GnomAD4 exome
AF:
0.00888
AC:
12850
AN:
1447520
Hom.:
138
Cov.:
35
AF XY:
0.00883
AC XY:
6356
AN XY:
719614
show subpopulations
African (AFR)
AF:
0.00154
AC:
50
AN:
32382
American (AMR)
AF:
0.00528
AC:
217
AN:
41098
Ashkenazi Jewish (ASJ)
AF:
0.00395
AC:
100
AN:
25300
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39628
South Asian (SAS)
AF:
0.00513
AC:
424
AN:
82726
European-Finnish (FIN)
AF:
0.0547
AC:
2897
AN:
52976
Middle Eastern (MID)
AF:
0.0264
AC:
150
AN:
5678
European-Non Finnish (NFE)
AF:
0.00768
AC:
8506
AN:
1108058
Other (OTH)
AF:
0.00845
AC:
504
AN:
59674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
625
1250
1876
2501
3126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00978
AC:
1488
AN:
152162
Hom.:
22
Cov.:
33
AF XY:
0.0116
AC XY:
859
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.00142
AC:
59
AN:
41506
American (AMR)
AF:
0.00765
AC:
117
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00456
AC:
22
AN:
4824
European-Finnish (FIN)
AF:
0.0579
AC:
612
AN:
10574
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00941
AC:
640
AN:
67998
Other (OTH)
AF:
0.00854
AC:
18
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
76
151
227
302
378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00812
Hom.:
34
Bravo
AF:
0.00529
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.00623
AC:
24
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00780
AC:
67
ExAC
AF:
0.0110
AC:
1339
Asia WGS
AF:
0.00144
AC:
5
AN:
3476
EpiCase
AF:
0.00792
EpiControl
AF:
0.00866

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CENPF: BP4, BS2 -

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 24, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
12
DANN
Benign
0.16
DEOGEN2
Benign
0.018
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.30
N
LIST_S2
Benign
0.57
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-1.0
T
PhyloP100
1.6
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.18
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.70
P
Vest4
0.028
MPC
0.053
ClinPred
0.0072
T
GERP RS
2.4
Varity_R
0.015
gMVP
0.051
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114717799; hg19: chr1-214815304; API